Actinium Pharmaceuticals
ATNM
#9636
Rank
โ‚น3.40 B
Marketcap
โ‚น109.21
Share price
0.79%
Change (1 day)
-81.44%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2024 (TTM): -โ‚น3.54 Billion

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are N/A. , an increase over its 2023 earnings that were of -โ‚น4.43 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚น3.6 Billion-18.87%
2023 -โ‚น4.43 Billion52.24%
2022 -โ‚น2.91 Billion36.61%
2021 -โ‚น2.13 Billion11.48%
2020 -โ‚น1.92 Billion1.46%
2019 -โ‚น1.89 Billion-7.37%
2018 -โ‚น2.04 Billion-11.46%
2017 -โ‚น2.3 Billion10.67%
2016 -โ‚น2.08 Billion15.7%
2015 -โ‚น1.8 Billion-14.86%
2014 -โ‚น2.11 Billion129.19%
2013 -โ‚น0.92 Billion-8.55%
2012 -โ‚น1.01 Billion
2010 โ‚น0.7 M-152.15%
2009 -โ‚น1.36 Million-39.8%
2008 -โ‚น2.26 Million120.29%
2007 -โ‚น1.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚น3.18 Billion-11.70%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น46.22 B-1,386.21%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น2.46 Billion-31.73%๐Ÿ‡บ๐Ÿ‡ธ USA